Lakefront Biotherapeutics (LKFT) Goodwill (2022 - 2025)

Lakefront Biotherapeutics (LKFT) has 4 years of Goodwill data on file, last reported at $78.3 million in Q2 2025.

• Goodwill for Q2 2025 came in at $78.3 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $78.3 million (changed N/A YoY), and the FY2024 annual result was $74.8 million, changed 0.04% from the prior year.
• Goodwill improved to $78.3 million in Q2 2025 per LKFT's latest filing, from $73.3 million in the prior quarter.
• Over five years, Goodwill peaked at $78.3 million in Q2 2025 and troughed at $71.2 million in Q4 2022.
• A 4-year average of $75.0 million and a median of $74.8 million in 2023 frame the typical range for Goodwill.
• The sharpest annual moves came in 2023 and 2025: Goodwill rose 5.07% in 2023, then dropped 3.18% in 2025.
• A 4-year view of Goodwill shows it stood at $71.2 million in 2022, then grew by 5.07% to $74.8 million in 2023, then fell by 0.04% to $74.8 million in 2024, then advanced by 4.63% to $78.3 million in 2025.
• Business Quant data shows LKFT's Goodwill at $78.3 million in Q2 2025, $73.3 million in Q1 2025, and $74.8 million in Q4 2024.